Leaflet LINEZOLID KRKA 2mg / ml solution for infusion


Indicated for: bacterial infections

Route of administration: infusion

Substance: linezolid (antibacterial antibiotic)

ATC: J01XX08 (Antiinfectives for systemic use | Other antibacterials)

Linezolid is an antibiotic from the oxazolidinone class, used to treat severe bacterial infections caused by gram-positive resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). It is indicated for infections such as pneumonia, skin and soft tissue infections, and other complicated infections.

Linezolid works by inhibiting bacterial protein synthesis, blocking the formation of the translation initiation complex, which halts bacterial growth. It is available in tablet form, oral solution, or injectable solution.

Side effects may include nausea, diarrhea, headache, anemia, thrombocytopenia (low platelet count), or peripheral neuropathy with prolonged use. Linezolid can also interact with foods high in tyramine (such as aged cheeses or red wine) and certain medications, increasing the risk of serotonin syndrome. It is important to take the medication as prescribed by a doctor and for patients to be monitored for side effects.

General data about LINEZOLID KRKA 2mg / ml

  • Substance: linezolid
  • Date of last drug list: 01-05-2026
  • Commercial code: W63515001
  • Concentration: 2mg / ml
  • Pharmaceutical form: solution for infusion
  • Quantity: 1
  • Product type: generic
  • Price: 268.42 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 14216/2021/01
  • Shelf life: 2 years-after packaging for sale;after the first opening-a se utiliza imediat

Pharmaceutical forms available for linezolid

Concentrations available for linezolid

  • 100mg/5ml
  • 2mg/ml
  • 400mg
  • 600mg

Compensation lists for LINEZOLID KRKA 2mg / ml KRKA

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.2 (C2) - Heart transplant

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.3 (C2) - Liver Transplant

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.5 (C2) - Pancreatic cell transplantation

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON

NHP 9.6 (C2) - Lung transplant

Price

Copayment

Patient

268.42 RON

167.37 RON

101.05 RON